Alessandra Dodi

PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors

Roberta Minari, Francesco Bonatti, Giulia Mazzaschi et al. · Tumori Journal · 2021 · 38 citations

Medicine, Molecular Genetics, Oncology +17

Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic

Serena Zuliani, Ilaria Zampiva, Daniela Tregnago et al. · European Journal of Cancer · 2020 · 31 citations · Full text

Medicine, Infectious Diseases, Oncology +13

Body composition derangements in lung cancer patients treated with first‐line pembrolizumab: A multicentre observational study

Ilaria Trestini, Lorenzo Belluomini, Alessandra Dodi et al. · Journal of Cachexia Sarcopenia and Muscle · 2024 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

The myokine irisin: localization and effects in swine late medium and large antral ovarian follicle

Giuseppina Basini, Simona Bussolati, Mattia Iannarelli et al. · Domestic Animal Endocrinology · 2020 · 24 citations

Medicine, Gynecology, Physiology +15

Integrating supportive care into the multidisciplinary management of lung cancer: we can’t wait any longer

Alice Avancini, Lorenzo Belluomini, Anita Borsati et al. · Expert Review of Anticancer Therapy · 2022 · 13 citations

Medicine, Oncology, Cancer Symptom Management +14